Results at Week 56 in a Trial of OZEMPIC Compared to Sitagliptin in Adult Patients with Type 2 Diabetes Mellitus in Combination with Metformin and/or Thiazolidinediones The mean baseline body weight was 89.9 kg, 89.2 kg, 89.3 kg in the OZEMPIC 0.5 mg, OZEMPIC 1 mg, and sitagliptin arms, respectively
For insulin users, this significantly increases the risk of blood sugar swings
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Menstrual cycle phase modulates reward-related neural function in women
pricing pressure, Novo is girding for competition from Eli Lilly on the oral weight-loss front as the Indianapolis-based drugmaker expects to launch its own pill in the second quarter
This documentation supports your quality verification and regulatory requirements